Cas:83282-39-7 4-butylpyridine-2-carboxylic acid manufacturer & supplier

We serve Chemical Name:4-butylpyridine-2-carboxylic acid CAS:83282-39-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-butylpyridine-2-carboxylic acid

Chemical Name:4-butylpyridine-2-carboxylic acid
CAS.NO:83282-39-7
Synonyms:4-butyl-pyridine-2-carboxylic acid;2-Pyridinecarboxylicacid,4-butyl;4-n-butyl-2-pyridinecarboxylic acid;4-Butyl-pyridin-2-carbonsaeure;4-n-Butylpyridine-2-carboxylic acid;4-n-Butylpyridinepicolinic acid
Molecular Formula:C10H13NO2
Molecular Weight:179.21600
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:338.6ºC at 760 mmHg
Density:1.113 g/cm3
Index of Refraction:1.534
PSA:50.19000
Exact Mass:179.09500
LogP:2.12240

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-butyl-pyridine-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-n-Butylpyridinepicolinic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Pyridinecarboxylicacid,4-butyl Use and application,4-butyl-pyridine-2-carboxylic acid technical grade,usp/ep/jp grade.


Related News: Charles River looks forward to continuing its ongoing partnership with AstraZeneca. It was great to join the team today, to see the facility for myself and congratulate them on this really significant expansion, which will see an €8m investment, creating 90 new jobs for Mayo. 2-[Acetyl-(4-trifluoromethyl-phenyl)-amino]-N-(4-sulfamoyl-phenyl)-acetamide manufacturers The Plexxikon patents are for compounds that reduce cancer cell growth by blocking V600E mutated BRAF. Patents were filed as early as 2005. N-(4-{4-[2-(4-1,2-benzisothiazol-3-yl-piperazin-1-yl)-ethoxy]-phenylsulfamoyl}-phenyl)-acetamide suppliers The development of various enabling technologies has been critical in expanding the potential of biocatalytic processing, as well as in promoting its uptake across the pharmaceutical industry. D-Galaktose-hexylhydrazon vendor & factory.